Clinical Trials Browser

Urogenital Diseases, Uterine Cervical Diseases, Uterine Cervical Neoplasms, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Female, Neoplasms by Site, Uterine Diseases, Uterine Neoplasms, Female Urogenital Diseases

NCT04024254 2026-03-04

A Study of Serum Folate Levels in Patients Treated With Olaparib

Phase 4 Completed

10 enrolled 14 charts

BreastGynecologic

Breast Neoplasms, Folic Acid Deficiency, Ovarian Neoplasms

NCT05334706 2026-02-23

RIFT-HPV

Phase 4 Recruiting

69 enrolled

Gynecologic

Uterine Cervical Neoplasms, Infections, Papillomavirus Infections, Squamous Intraepithelial Lesions of the Cervix

NCT07281547 2026-02-18

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

Phase 4 Not yet recruiting

25 enrolled

Gynecologic

Endometrial Neoplasms

NCT07412873 2026-02-17

PROVIDENCE

Phase 4 Not yet recruiting

120 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06786429 2026-01-21

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

Phase 4 Not yet recruiting

1,800 enrolled

GastrointestinalGynecologic

Anxiety Disorders, Uterine Cervical Neoplasms, Depression, Hepatitis B, Carcinoma, Hepatocellular, Gallstones

NCT07015957 2026-01-12

Kupewa: Optimizing Implementation Strategies for Cervical Cancer Prevention

Phase 4 Active not recruiting

7,000 enrolled

Gynecologic

Cervical Cancer Prevention

NCT04145518 2025-12-12

MCUP

Phase 4 Completed

183 enrolled

Gynecologic

Dysmenorrhea, Leiomyoma, Pain, Uterine Diseases

NCT06121401 2025-09-17

IOLANTHE

Phase 4 Active not recruiting

190 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial

NCT07075250 2025-07-20

RIFOC003

Phase 4 Not yet recruiting

30 enrolled

Gynecologic

Platinum-resistant Ovarian Cancer (PROC)

NCT06897527 2025-07-08

A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)

Phase 4 Not yet recruiting

100 enrolled

Gynecologic

Endometrial Neoplasms

NCT01932125 2025-06-26

An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Phase 4 Completed

100 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT04861181 2025-05-22

NIRAPK

Phase 4 Terminated

12 enrolled

Classical hematologyGynecologic

Ovarian Neoplasms, Recurrence, Thrombocytopenia

NCT06972693 2025-05-15

PERSONA-Ovary

Phase 4 Active not recruiting

323 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05266898 2025-04-18

AGO-Gard

Phase 4 Recruiting

250 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

Clinical Trials

PRISMA

RESToRE

CervALONE

Study Evaluating Safety, Tolerability, and Metabolism of Niraparib

CYTALUX Dose Extension Study

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

A Study of Serum Folate Levels in Patients Treated With Olaparib

RIFT-HPV

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

PROVIDENCE

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

Kupewa: Optimizing Implementation Strategies for Cervical Cancer Prevention

MCUP

IOLANTHE

RIFOC003

A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)

An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

NIRAPK

PERSONA-Ovary

AGO-Gard